Literature DB >> 23948911

Tetrahydrohyperforin induces mitochondrial dynamics and prevents mitochondrial Ca2+ overload after Aβ and Aβ-AChE complex challenge in rat hippocampal neurons.

Juan M Zolezzi1, Francisco J Carvajal, Juvenal A Ríos, Daniela Ordenes, C Silva-Alvarez, Juan A Godoy, Nibaldo C Inestrosa.   

Abstract

St. John's wort has been the subject of studies focused on its therapeutic properties against several diseases, including Alzheimer's disease (AD). Amyloid β-peptide (Aβ), a critical peptide in AD, has been linked to the mitochondrial dysfunction often observed in this disease. Despite many efforts to prevent Aβ levels from increasing in AD, less has been done regarding the mitochondrial component. Therefore, we studied the effects of tetrahydrohyperforin (THH) on mitochondrial dysfunction of hippocampal neurons, challenged with Aβ oligomers (Aβo) and Aβo-AChE complexes. We show that THH prevents mitochondrial calcium overload and induces the modulation of fusion-fission events, arresting mitochondrial dysfunction. Moreover, our results suggest that the modulation of mitochondrial dynamics probably occurs through a peroxisome proliferator-activated receptor γ co-activator 1α-mediated mechanism, inducing mitochondrial fusion-fission protein expression. Our results offer further explanation for the effects observed for THH and the beneficial effects of this ethno-botanical drug in AD.

Entities:  

Keywords:  Calcium; DRP1; FIS1; PGC-1α; mitochondrial fusion-fission; neurodegeneration

Mesh:

Substances:

Year:  2013        PMID: 23948911     DOI: 10.3233/JAD-130173

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

1.  Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment.

Authors:  Hua Zhang; Suya Sun; Lili Wu; Ekaterina Pchitskaya; Olga Zakharova; Klementina Fon Tacer; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2016-11-23       Impact factor: 6.167

2.  Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease.

Authors:  Elena Popugaeva; Daria Chernyuk; Ilya Bezprozvanny
Journal:  Curr Alzheimer Res       Date:  2020       Impact factor: 3.498

3.  Tetrahydrohyperforin: a neuroprotective modified natural compound against Alzheimer's disease.

Authors:  Carla Montecinos-Oliva; Andreas Schüller; Nibaldo C Inestrosa
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

Review 4.  Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.

Authors:  Juan M Zolezzi; Sussy Bastías-Candia; Manuel J Santos; Nibaldo C Inestrosa
Journal:  Front Aging Neurosci       Date:  2014-07-28       Impact factor: 5.750

Review 5.  Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders.

Authors:  Zhibin Liang; Antonio Currais; David Soriano-Castell; David Schubert; Pamela Maher
Journal:  Pharmacol Ther       Date:  2020-11-20       Impact factor: 12.310

Review 6.  Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?

Authors:  Rafael Franco; Angel Cedazo-Minguez
Journal:  Front Pharmacol       Date:  2014-06-25       Impact factor: 5.810

7.  Overexpression of COX6B1 protects against I/R‑induced neuronal injury in rat hippocampal neurons.

Authors:  Shan Yang; Peng Wu; Jianwen Xiao; Li Jiang
Journal:  Mol Med Rep       Date:  2019-04-10       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.